Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s): CLAZF

Healthcare

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID viruses on contact. R-107 targets the Achilles heel of COVID, the spike protein on the surface of the virus. R-107 releases nitric oxide, which attaches to a specific amino acid on the spike protein, thereby disabling the spike protein. The CLA-1816 provides effective pain reduction, without the risks of addiction or respiratory suppression that exist with opioid analgesics. CLA-1816 strongly binds with and activates the alpha3 glycine pain receptor in the spine. The Company has leased a laboratory, office, and archival space in Beverly, Massachusetts.

TSXV:CLAS.H - Post by User

Claritas Pharmaceuticals Inc

<< Previous

Bullboard Posts

Next >>

Post by HighSkies2019on Feb 07, 2021 2:41pm

204 Views

Post# 32496377

Appreciate Others Imput

Well I have to give credit to individuals who take on the responsibility running a website ... its a lot of work maintaining...what is provided and posted on these sites are not always favorable to everyone ... but the knowledge of what you want to take away would depend on your own individual DD ... some are just too lazy ...even though spoon fed with info...some will do nothing but whine and bark and try to belittle others ...yet will still follow that site... if we didn't have such sites we would not have gotten the slip on the Kly booboo ... what I read certainly makes the anticipation of getting unsalted exciting...and yes when I see the legit NR I will consider written in stone ..glta

<< Previous

Bullboard Posts

Next >>

Investors eye Australian gold mining projects amid promising developments